Direct and indirect suppression of interleukin-6 gene expression in murine macrophages by nuclear orphan receptor REV-ERBα
Related Experiment Video
Updated: Apr 20, 2026

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages
Published on: November 3, 2014
Shogo Sato1, Takuya Sakurai1, Junetsu Ogasawara1
1Department of Molecular Predictive Medicine and Sport Science, Kyorin University, School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan.
Abstract:
It is now evident that many nuclear hormone receptors can modulate target gene expression. REV-ERBα, one of the nuclear hormone receptors with the capacity to alter clock function, is critically involved in lipid metabolism, adipogenesis, and the inflammatory response. Recent studies suggest that REV-ERBα plays a key role in the mediation between clockwork and inflammation. The purpose of the current study was to investigate the role of REV-ERBα in the regulation of interleukin-6 (il6) gene expression in murine macrophages. REV-ERBα agonists, or overexpression of rev-erb α in the murine macrophage cell line RAW264 cells, suppressed the induction of il6 mRNA following a lipopolysaccharide (LPS) endotoxin challenge. Also, rev-erb α overexpression decreased LPS-stimulated nuclear factor κB (NFκB) activation in RAW264 cells. We showed that REV-ERBα represses il6 expression not only indirectly through an NFκB binding motif but also directly through a REV-ERBα binding motif in the murine il6 promoter region. Furthermore, peritoneal macrophages from mice lacking rev-erb α increased il6 mRNA expression. These data suggest that REV-ERBα regulates the inflammatory response of macrophages through the suppression of il6 expression. REV-ERBα may therefore be identified as a potent anti-inflammatory receptor and be a therapeutic target receptor of inflammatory diseases.
Insights
REV-ERBα, a nuclear receptor, suppresses interleukin-6 (IL-6) gene expression in macrophages, acting as a key regulator of the inflammatory response and a potential therapeutic target for inflammatory diseases.
Area of Science:
- Molecular biology
- Endocrinology
- Immunology
Background:
- Nuclear hormone receptors modulate gene expression.
- REV-ERBα influences lipid metabolism, adipogenesis, and inflammation.
- REV-ERBα links circadian clock function with inflammatory pathways.
Purpose of the Study:
- To investigate REV-ERBα's role in regulating interleukin-6 (IL-6) gene expression in murine macrophages.
- To elucidate the mechanisms by which REV-ERBα affects IL-6 expression.
Main Methods:
- Utilized REV-ERBα agonists and overexpression in RAW264 macrophage cell line.
- Administered lipopolysaccharide (LPS) to stimulate IL-6 induction.
- Assessed nuclear factor κB (NFκB) activation.
- Analyzed IL-6 promoter regions for REV-ERBα and NFκB binding sites.
- Examined peritoneal macrophages from REV-ERBα knockout mice.
Main Results:
- REV-ERBα agonists and overexpression suppressed LPS-induced IL-6 mRNA.
- REV-ERBα overexpression reduced LPS-stimulated NFκB activation.
- REV-ERBα directly represses IL-6 via its promoter binding motif and indirectly via NFκB.
- Macrophages lacking REV-ERBα exhibited increased IL-6 mRNA expression.
Conclusions:
- REV-ERBα acts as a negative regulator of IL-6 expression in macrophages.
- REV-ERBα suppresses the inflammatory response by controlling IL-6.
- REV-ERBα is a potential anti-inflammatory target for treating inflammatory diseases.
Related Concept Videos
Co-activators and Co-repressors
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

